Perjeta for Breast Cancer, Adjuvant
What is Perjeta for Breast Cancer, Adjuvant Treatment?
Perjeta (pertuzumab) is a medication used in the treatment of certain types of breast cancer, specifically in the adjuvant setting. Adjuvant treatment refers to therapy given after primary treatment, such as surgery, to reduce the risk of cancer recurrence. Perjeta is designed to work in conjunction with other medications, like Herceptin (trastuzumab), to target and eliminate cancer cells.
How Does Perjeta Work?
Perjeta is a monoclonal antibody that targets the HER2 protein on the surface of cancer cells. By binding to this protein, Perjeta prevents the growth and spread of cancer cells. In the context of breast cancer, Perjeta is often used in combination with other medications to treat HER2-positive breast cancer. This type of breast cancer accounts for about 20% of all breast cancer cases and is characterized by an overexpression of the HER2 protein.
Perjeta for Breast Cancer, Adjuvant Side Effects
Common Side Effects of Perjeta
Perjeta is a medication used to treat certain types of breast cancer, including breast cancer, adjuvant. When used as part of a treatment plan, Perjeta can cause a range of side effects. Some common side effects of Perjeta include:
- Fatigue and weakness
- Nausea and vomiting
- Diarrhea
- Abdominal pain
- Muscle and joint pain
Less Common but Serious Side Effects
While rare, some patients taking Perjeta for breast cancer, adjuvant may experience more serious side effects. These can include:
- Heart problems, such as heart failure or abnormal heart rhythms
- Lung problems, such as pneumonitis or pulmonary embolism
- Liver problems, such as elevated liver enzymes or liver failure
- Severe allergic reactions, such as anaphylaxis
Managing Side Effects of Perjeta
If you are taking Perjeta for breast cancer, adjuvant, it is essential to discuss any side effects with your doctor. They can help you manage side effects and adjust your treatment plan as needed. Some ways to manage side effects include:
- Taking medication to reduce nausea and vomiting
- Getting plenty of rest and staying hydrated
- Eating a balanced diet to help manage diarrhea and abdominal pain
- Engaging in gentle exercise to reduce muscle and joint pain
In some cases, side effects of Perjeta can be severe and require immediate medical attention. If you experience any of the following, seek medical help right away:
- Severe difficulty breathing
- Chest pain or pressure
- Severe abdominal pain
- Severe allergic reactions, such as difficulty breathing, swelling, or hives
By understanding the potential side effects of Perjeta and working closely with your doctor, you can help minimize the impact of side effects and focus on your breast cancer, adjuvant treatment.
Perjeta for Breast Cancer, Adjuvant Reviews
Overview
Perjeta is a medication used to treat certain types of breast cancer. When used in conjunction with other treatments, Perjeta can help prevent the return of breast cancer after initial treatment. Here, you can find information and reviews on Perjeta for breast cancer, adjuvant treatment.
What You Need to Know
Perjeta is administered in combination with other medications to help reduce the risk of breast cancer recurrence. The medication works by targeting specific proteins that cancer cells use to grow and spread. For patients with breast cancer, adjuvant treatment is a crucial step in ensuring the cancer does not return. Reviews of Perjeta for breast cancer, adjuvant treatment have shown promising results in terms of efficacy and safety.
Finding Reliable Reviews
When searching for reviews on Perjeta for breast cancer, adjuvant treatment, it’s essential to look for credible sources. Reviews from medical professionals, patients, and online forums can provide valuable insights into the medication’s effectiveness. Reading multiple reviews can help you make an informed decision about your treatment options. Perjeta reviews can be found on various websites, including those of pharmaceutical companies, medical organizations, and patient advocacy groups.